Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
Jennifer Le Guévelou(Centre Eugène Marquis), I. Latorzeff(Clinique Pasteur), Pierre Blanchard(Inserm), Paul Sargos, Christophe Hennequin(Inserm), R. de Crevoisier(Centre Eugène Marquis), S. Supiot(Institut de Cancérologie de l'Ouest), G. Créhange(Centre Georges François Leclerc), Manon Baty(Centre Eugène Marquis), O. Chapet(Université Claude Bernard Lyon 1), L. Ferretti, Ulrike Schick(Centre Hospitalier Régional Universitaire de Brest), Guillaume Ploussard(Yves Rocher (France)), Ingrid Masson(Centre Eugène Marquis)
Cited by 12
Related Papers
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
|The Lancet Oncology|2014|446
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
|Journal of Clinical Oncology|2012|431
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysis
|Radiotherapy and Oncology|2016|231
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
|International Journal of Radiation Oncology*Biology*Physics|2020|211